Misoprostol for the treatment of postpartum hemorrhage (PPH) was added to the World Health Organisation’s 19th Model List of Essential Medicines (EML).  This one-page document summarizes the decision reached by the 20th Expert Committee on the Selection and Use of Essential Medicines when in April 2015 it met at the WHO Headquarters in Geneva to revise and update the EML for both adults and children.

Published:
May. 2015
Type:
Topic:
Authors:
Gynuity Health Projects

PDF

PDF

Not all resources are available in all formats. Select language to check availability.